{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:20:04Z","timestamp":1783653604232,"version":"3.55.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by mutations in the <jats:italic>TSC1<\/jats:italic> or <jats:italic>TSC2<\/jats:italic> genes, leading to dysregulation of the mTOR pathway and multisystemic manifestations. Epilepsy is a common neurologic feature of TSC, frequently accompanied by neuropsychiatric comorbidities. Understanding the relationship between epilepsy severity, TSC-associated neuropsychiatric disorders (TAND), and cognitive outcomes is crucial for optimizing patient care.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective study was conducted at a pediatric tertiary care hospital in Qatar, involving 38 TSC patients (20 female, 18 male) aged 1\u201318 years, diagnosed between October 2018 and March 2020. Epilepsy severity was assessed using the Early Childhood Epilepsy Severity Scale (E-Chess), and TAND was evaluated using the TAND checklist. Genetic analysis was performed for all patients, and statistical analyses were used to explore correlations between epilepsy severity, TAND, and cognitive outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The majority (82%) of TSC patients had epilepsy, with a mean onset age of 9.2 months. Uncontrolled seizures were associated with higher rates of intellectual disability and more pronounced TAND manifestations compared to controlled seizures. Autism spectrum disorder (ASD) was reported in 42% of the cohort, with significant correlations found between epilepsy severity and ASD-related domains on the TAND checklist. Intellectual disability was prevalent (67.6%), with variability attributed to genetic background and early severe neurological presentations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This study reinforces the link between epilepsy severity and neuropsychiatric comorbidities in TSC, confirming earlier findings. Significant correlations were observed between epilepsy severity and ASD-related domains, and the high prevalence of intellectual disability in TSC patients was highlighted. However, the relationship between ASD, TSC, and epilepsy remains complex and requires further investigation. Despite advances in treatment options, including mTOR inhibitors and newer antiepileptic drugs, unmet needs remain in the comprehensive care of TSC patients. Optimizing seizure control is a clear priority, but equally important is the need for addressing the cognitive and behavioral components of TAND. Early intervention with tailored, multidisciplinary approaches including neurology, psychiatry, psychology, and educational specialists could mitigate the long-term impact of these comorbidities, particularly in children. These approaches must be individualized to each patient's unique set of challenges, emphasizing not only seizure control but also psychosocial support and educational adaptation to improve their overall quality of life.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study sheds light on the intricate interactions between epilepsy severity, neuropsychiatric manifestations, and cognitive outcomes in TSC patients. The findings emphasize the need for tailored management approaches, focusing on early seizure control and comprehensive multidisciplinary care. Further research is required to clarify the mechanisms underlying these associations and to develop targeted interventions for improving the quality of life for individuals with TSC and epilepsy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2024.1436061","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T04:11:24Z","timestamp":1736914284000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Neuropsychiatric profile in tuberous sclerosis complex patients with epilepsy"],"prefix":"10.3389","volume":"12","author":[{"given":"Mahmoud Fawzi","family":"Osman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Hadid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawfeg","family":"ben Omran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munira","family":"Aden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Al-Maadid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sondos","family":"Altaraqji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruba","family":"Benini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1001\/jama.1983.03330340044029","article-title":"Family studies in tuberous sclerosis","volume":"249","author":"Cassidy","year":"1983","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/TACG.S90262","article-title":"Genetics of tuberous sclerosis complex: implications for clinical practice","volume":"10","author":"Caban","year":"2017","journal-title":"Appl Clin Genet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1111\/bjd.14415","article-title":"An estimation of the incidence of tuberous sclerosis complex in a nationwide retrospective cohort study (1997\u20132010)","volume":"174","author":"Hong","year":"2016","journal-title":"Br J Dermatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e63910","DOI":"10.1371\/journal.pone.0063910","article-title":"Trends in the prevalence of tuberous sclerosis complex manifestations: an epidemiological study of 166 Japanese patients","volume":"8","author":"Wataya-Kaneda","year":"2013","journal-title":"PLoS One"},{"key":"B5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13023-019-1090-9","article-title":"Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study","volume":"14","author":"Ebrahimi-Fakhari","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.yebeh.2011.08.037","article-title":"Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis","volume":"22","author":"Cusmai","year":"2011","journal-title":"Epilepsy Behav"},{"key":"B7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/epi4.12286","article-title":"Epilepsy in tuberous sclerosis complex: findings from the TOSCA study","volume":"4","author":"Nabbout","year":"2019","journal-title":"Epilepsia Open"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.1528-1167.2009.02474.x","article-title":"The natural history of epilepsy in tuberous sclerosis complex","volume":"51","author":"Chu-Shore","year":"2010","journal-title":"Epilepsia"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e2019125","DOI":"10.4322\/acr.2019.125","article-title":"Multiple cardiac rhabdomyomas in tuberous sclerosis complex: case report and review of the literature","volume":"9","author":"Frudit","year":"2019","journal-title":"Autops Case Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.nurt.2010.05.001","article-title":"Targeted treatments for cognitive and neurodevelopmental disorders in tuberous sclerosis complex","volume":"7","author":"De Vries","year":"2010","journal-title":"Neurotherapeutics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/ajmg.c.31637","article-title":"A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)","volume":"178","author":"De Vries","year":"2018","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.yebeh.2017.09.017","article-title":"Epilepsy may be the major risk factor of mental retardation in children with tuberous sclerosis: a retrospective cohort study","volume":"77","author":"Wang","year":"2017","journal-title":"Epilepsy Behav"},{"key":"B13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/dmcn.14055","article-title":"Tuberous sclerosis-associated neuropsychiatric disorders: a paediatric cohort study","volume":"61","author":"Toldo","year":"2019","journal-title":"Dev Med Child Neurol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4137\/JCNSD.S6371","article-title":"Safety and efficacy of vigabatrin for the treatment of infantile spasms","volume":"3","author":"Faulkner","year":"2011","journal-title":"J Cent Nerv Syst Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1528-1167.2007.01035.x","article-title":"Tuberous sclerosis complex and epilepsy: recent developments and future challenges","volume":"48","author":"Holmes","year":"2007","journal-title":"Epilepsia"},{"key":"B16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.eplepsyres.2008.01.007","article-title":"The early childhood epilepsy severity scale (E-chess)","volume":"79","author":"Humphrey","year":"2008","journal-title":"Epilepsy Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3389\/fneur.2020.00639","article-title":"Autism and epilepsy in patients with tuberous sclerosis complex","volume":"11","author":"Specchio","year":"2020","journal-title":"Front Neurol"},{"key":"B18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-137-01368-2","volume-title":"Mental Health, Race and Culture","author":"Fernando","year":"2010"},{"key":"B19","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ejpn.2011.03.010","article-title":"Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex","volume":"15","author":"J\u00f3\u017awiak","year":"2011","journal-title":"Eur J Paediatr Neurol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yebeh.2017.02.007","article-title":"Influence of seizures on early development in tuberous sclerosis complex","volume":"70","author":"Capal","year":"2017","journal-title":"Epilepsy Behav"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/j.1528-1167.2008.01589.x","article-title":"Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile","volume":"49","author":"Camposano","year":"2008","journal-title":"Epilepsia"},{"key":"B22","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1177\/08830738040190090701","article-title":"Autism and tuberous sclerosis","volume":"19","author":"Wiznitzer","year":"2004","journal-title":"J Child Neurol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1136\/jmedgenet-2015-103154","article-title":"Intellectual ability in tuberous sclerosis complex correlates with predicted effects of mutations on TSC1 and TSC2 proteins","volume":"52","author":"Wong","year":"2015","journal-title":"J Med Genet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.pediatrneurol.2011.01.001","article-title":"Cortical tubers, cognition, and epilepsy in tuberous sclerosis","volume":"44","author":"Kassiri","year":"2011","journal-title":"Pediatr Neurol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3389\/fnins.2020.00899","article-title":"Progression of fetal brain lesions in tuberous sclerosis complex","volume":"14","author":"Gelot","year":"2020","journal-title":"Front Neurosci"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1436061\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T04:11:28Z","timestamp":1736914288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1436061\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":25,"alternative-id":["10.3389\/fped.2024.1436061"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1436061","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"article-number":"1436061"}}